Puretech Health PLC PTCHF

Annual Quarterly

FY2024 · ended Dec 31, 2024 · Revenue $4.32M, +475.3% YoY · Filed Apr 30, 2025

Puretech Health PLC (PTCHF) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2024, which ended Dec 31, 2024, it reported revenue of $4.3 million and net income of $27.8 million. Free cash flow was -$134.4 million. As of Dec 31, 2024 it held $280.6 million in cash and investments and $18.2 million in total debt.

Revenue
$4.32M
+475.3% vs prior year
Net income
$27.78M
+141.7% vs prior year
Operating cash flow
$-134.37M
-26.9% vs prior year
Free cash flow
$-134.38M
-26.8% vs prior year
EPS
$0.21
+187.5% vs prior year
Dividend per share
None
Shares outstanding
241.68M
+0.9% vs prior year
Net cash
$262.39M
FY 2024
Operating margin
-3154.0%
FY 2024

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTCHF (OTC), PRTCY (OTC)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Boston, MA
SEC filer status
Accelerated filer
SEC CIK
1782999

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
$4.3M
$750,000
$2.1M
$10.0M
$8.3M
Operating income
-$136.1M
-$146.2M
-$197.8M
-$150.3M
-$119.5M
Net income
$27.8M
-$66.6M
-$37.1M
-$62.7M
$4.6M
Diluted EPS
$0.21
-$0.24
-$0.18
-$0.21
$0.02
Operating cash flow
-$134.4M
-$105.9M
-$178.8M
-$158.3M
-$131.8M
Free cash flow
-$134.4M
-$106.0M
-$181.0M
-$163.8M
-$137.0M
Total assets
$602.6M
$694.0M
$702.6M
$946.0M
$990.0M
Total liabilities
$194.7M
$235.7M
$155.1M
$361.9M
$336.5M
Stockholders' equity
$407.9M
$458.2M
$547.6M
$584.1M
$653.5M
Cash and investments
$280.6M
$191.1M
$149.9M
$465.7M
$403.9M
Total debt
$18.2M
$21.6M
$44.5M
$48.1M
$50.2M

Recent SEC filings

Form Description Filed Period
6-K Current report (foreign issuer) May 1, 2026 May 1, 2026
20-F Annual report (foreign issuer) Apr 29, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Dec 10, 2025 Dec 10, 2025

All 134 Puretech Health PLC SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.